otherwise 100,- Zone 1 (EU) including Switzerland and United Kingdom (GB): Belgium, Bulgaria, Denmark (except Faroe Islands, Greenland), Estonia, Finland (except land Islands), France (except overseas territories and departments), Greece (except Mount Athos), United Kingdom (GB, except Channel Islands), Ireland, Italy (except Livigno and Campione d'Italia), Croatia, Latvia, Lithuania, Luxembourg, Malta, Monaco, Netherlands (except non-European territories), Austria, Poland, Portugal, Romania, Sweden, Slovakia, Slovenia, Spain (except Canary Islands, Ceuta + Melilla), Czech Republic, Hungary, Cyprus/Republic (except northern part), including Switzerland Zone 2 (Europe excluding the EU): land Islands (Finland), Andorra, Albania, Armenia, Azerbaijan, Mount Athos (GR), Bosnia and Herzegovina, Campione d'Italia (IT), Ceuta (E), Faroe Islands (DK), Georgia, Gibraltar (GB), Greenland (DK), Guernsey (GB), Iceland, Jersey (GB), Canary Islands (E), Kazakhstan , Kosovo (Serbian province), Liechtenstein, Livigno (IT), Macedonia, Melilla (E), Moldova (Republic), Montenegro (Republic), Norway, Russian Federation, San Marino, Serbia (Republic), Turkey, Ukraine, Vatican City, Belarus, Cyprus/Republic (northern part) Zone 3 (World): Egypt, Algeria, Bahrain, Iran, Iraq, Israel, Yemen, Jordan, Canada, Qatar, Kuwait, Lebanon, Libya, Morocco, Oman, Saudi Arabia, Syria Tunisia, USA, United Arab Emirates Zone 4 (Rest of the world): All countries and territories not assigned to Zones 1, 2 or 3
Neuroprotective effect of short-chain fatty acids against oxidative stressinduced SHSY5Y injury via GPR43dependent pathway
One of the primary mechanisms by which oncogenic KRAS promotes glycolysis is through the upregulation of glucose transporter (GLUT) proteins, particularly GLUT1, which facilitates increased glucose uptake [28,29,30,31]
Methods 11 , 783784 (2014)
